CPHI - China Pharma Holdings, Inc.
| Previous Close | 0.3601 |
| Open | 0.3600 |
| Bid | 0.3700 x 1000 |
| Ask | 0.3700 x 1000 |
| Day's Range | 0.3500 - 0.4100 |
| 52 Week Range | 0.1900 - 0.8400 |
| Volume | 2,117,851 |
| Avg. Volume | 957,414 |
| Market Cap | 15.384M |
| Beta (3Y Monthly) | 0.70 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.2470 |
| Earnings Date | Mar 29, 2019 - Apr 1, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.00 |
- PR Newswire•23 days ago
China Pharma Holdings, Inc. Reports Fiscal Year 2018 Financial Results
HAIKOU, China , March 29, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation ...
- Investopedia•3 months ago
Top 3 Healthcare Penny Stocks for 2018
These three healthcare penny stocks are poised for positive performance in the final quarter of 2018.
- GlobeNewswire•5 months ago
Investor Expectations to Drive Momentum within Cel-Sci, DGSE Companies, Veracyte, China Pharma, Barnwell Industries, and Silvercrest Asset Management Group — Discovering Underlying Factors of Influence
NEW YORK, Nov. 23, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
- PR Newswire•5 months ago
China Pharma Holdings, Inc. Reports Third Quarter 2018 Financial Results
HAIKOU CITY, China , Nov. 15, 2018 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE MKT: CPHI) (" China Pharma ," the " Company " or " We "), an NYSE American listed corporation ...
- PR Newswire•5 months ago
China Pharma Holdings, Inc. Launched Health Product Noni Enzyme ARARATO®
HAIKOU CITY, China, Nov. 13, 2018 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE MKT: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, announced today the launch of its health product Noni Enzyme ARARATO® to the market. Its native range extends across tropical islands of the South Pacific, and Hainan Island, China.
- PR Newswire•5 months ago
CPHI to Hold Third Quarter 2018 Earnings Conference Call On Thursday, November 15, 2018 at 8:30 a.m. ET
HAIKOU , China , Nov. 12, 2018 /PRNewswire/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE MKT: CPHI), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals ...
- PR Newswire•8 months ago
China Pharma Holdings, Inc. Reports Second Quarter 2018 Financial Results
HAIKOU CITY, China , Aug. 15, 2018 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE MKT: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American listed corporation ...
- PR Newswire•8 months ago
CPHI to Hold Second Quarter 2018 Earnings Conference Call on Wednesday August 15, 2018 at 8:30 a.m. ET
HAIKOU, China , Aug. 6, 2018 /PRNewswire/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE MKT: CPHI), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals ...
- ACCESSWIRE•11 months ago
Free Stock Performance Review on Pfizer and Three More Drug Makers’ Stocks
Stock Research Monitor: AZN, CPHI, and MRK LONDON, UK / ACCESSWIRE / May 15, 2018/ If you want a free Stock Review on PFE sign up now at www.wallstequities.com/registration . This morning, WallStEquities.com ...
- PR Newswire•11 months ago
China Pharma Holdings, Inc. Reports First Quarter 2018 Financial Results
HAIKOU, China , May 15, 2018 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE MKT: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American listed corporation with ...
- PR Newswire•11 months ago
CPHI to Hold First Quarter 2018 Earnings Conference Call On Tuesday May 15, 2018 at 8:30 a.m. ET
HAIKOU, China , May 8, 2018 /PRNewswire/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE MKT: CPHI), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary ...
